Skip to main content
Top
Published in: AIDS and Behavior 5/2020

01-05-2020 | Human Immunodeficiency Virus | Original Paper

Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018

Authors: Willi McFarland, Jessica Lin, Glenn-Milo Santos, Sean Arayasirikul, Henry Fisher Raymond, Erin Wilson

Published in: AIDS and Behavior | Issue 5/2020

Login to get access

Abstract

We examined PrEP awareness and use among people who inject drugs (PWID) in San Francisco in 2018. Of 397 respondents not known to be HIV positive, 56.7% had heard of PrEP, 38.9% knew that PrEP can prevent HIV transmission from sharing injection equipment, 13.6% had discussed PrEP with a health care provider, and 3.0% had used PrEP in the last 12 months. All seven male PWID who had used PrEP were also men who had sex with men. There is urgent need to improve messaging on PrEP’s effectiveness for PWID and to tailor ways of engaging PWID in PrEP programs.
Literature
6.
go back to reference Roth A, Tran N, Piecara B, Welles S, Shinefeld J, Brady K. Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: National HIV Behavioral Surveillance, 2015. AIDS Behav. 2019;23(7):1833–40.CrossRef Roth A, Tran N, Piecara B, Welles S, Shinefeld J, Brady K. Factors associated with awareness of pre-exposure prophylaxis for HIV among persons who inject drugs in Philadelphia: National HIV Behavioral Surveillance, 2015. AIDS Behav. 2019;23(7):1833–40.CrossRef
7.
go back to reference Sherman SG, Schneider KE, Park JN, et al. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019;195:148–55.CrossRef Sherman SG, Schneider KE, Park JN, et al. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019;195:148–55.CrossRef
8.
go back to reference Bazzi AR, Biancarelli DL, Childs E, et al. Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care STDS. 2018;32(12):529–37.CrossRef Bazzi AR, Biancarelli DL, Childs E, et al. Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care STDS. 2018;32(12):529–37.CrossRef
9.
go back to reference Edelman EJ, Moore BA, Calabrese SK, et al. Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS Behav. 2017;21(4):1025–33.CrossRef Edelman EJ, Moore BA, Calabrese SK, et al. Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS Behav. 2017;21(4):1025–33.CrossRef
11.
go back to reference Strathdee SA, Shoptaw S, Dyer TP, Quan VM, Aramrattana A. Substance use scientific committee of the HIV prevention trials network. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention. Curr Opin HIV AIDS. 2012;7(4):320–5.CrossRef Strathdee SA, Shoptaw S, Dyer TP, Quan VM, Aramrattana A. Substance use scientific committee of the HIV prevention trials network. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention. Curr Opin HIV AIDS. 2012;7(4):320–5.CrossRef
Metadata
Title
Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018
Authors
Willi McFarland
Jessica Lin
Glenn-Milo Santos
Sean Arayasirikul
Henry Fisher Raymond
Erin Wilson
Publication date
01-05-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02682-7

Other articles of this Issue 5/2020

AIDS and Behavior 5/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.